Fertility Test Market Analysis by Product (Ovulation Prediction Kits, and Fertility Monitors); by Mode of Purchase (OTC, Prescription, and Online); and by End User (Home Care, Fertility Clinics, and Hospitals) – Global Supply & Demand Analysis & Opportunity Outlook 2023-2035
Buy Now
In 2023, market players might incur losses due to huge gap in currency translation followed by contracting revenues, shrinking profit margins & cost pressure on logistics and supply chain.
Controlling Inflation has become the first priority for global economies from last quarter of 2022 and to be followed in 2023. With skewed economic situations, rise in interest rate by governments to control spending and inflation, spiked oil and gas prices, high inflation, geo-political issues including U.S. & China trade war, Russia-Ukraine conflict to intensify the global economic issues.
The interest rates in the U.S. may be less sensitive in 2023 as compared to 2022; sigh of relief for businesses. Positive business sentiments, healthy business balance sheets, growth in construction spending (private construction value in 2022 stood at $1,429.2 billion, 11.7 percent (±1.0 percent) above the $1,279.5 billion spent in 2021, Residential construction in 2022 was $899.1 billion, up by 13.3 percent (±2.1 percent) from $793.7 billion in 2021, non-residential construction touched $530.1 billion, 9.1 percent (±1.0 percent) above the $485.8 billion in 2021.) showcases minimal impact of recession in the country.
Similarly, spiked spending in the European and major Asia economics including, India, China & Japan to showcase less impact on the global demand.
Kindbody launched the Kind at Home fertility test for both men and women. It can be easily used at home; it also provides detailed information about the fertility status along with customizes recommendation by doctors.
Fertility Focus launched the OvyFirst, it is sensor device which estimates the body temperature and predict best time for the women to conceive
Fertility test aids the ovulation detection and/or the diagnosis of infertility, or the inability to conceive naturally. A difficulty with one or more phases in the conception process is frequently the cause of infertility. Fertility test are made for both males and females. It can be easily conducted at home or can be done under the supervision of the doctor. Doctors can identify the causes of infertility with the aid of fertility tests. Laboratory, imaging, and other tests that reveal details about a person's reproductive organs and the process of getting pregnant are used to identify the causes of infertility.
|
Base Year |
2022 |
|
Forecast Year |
2023-2035 |
|
CAGR |
~8% |
|
Base Year Market Size (2022) |
~ USD 500 Million |
|
Forecast Year Market Size (2035) |
~ USD 1200 Million |
|
Regional Scope |
|
The global fertility test market is estimated to garner a revenue of USD 1200 Million by the end of 2035 by growing at a CAGR of ~8% over the forecast period, i.e., 2023 – 2035. Further, the market generated a revenue of USD 500 Million in the year 2022. The market growth is primarily being attributed to the growing prevalence of polycystic ovarian syndrome among female population. Between 4% and 20% of people worldwide are believed to have PCOS. According to estimates from the World Health Organization (WHO), PCOS affects about 116 million women worldwide (3.4%).
Get more information on this report:Download Sample PDF
Besides this, the rise in the number of people suffering with infertility is expected to boost the growth of the fertility test market. There are many factors that contribute to infertility, including low sperm count and limited sperm motility in men and failure to ovulate, damaged cervixes and fallopian tubes in women. The World Health Organization (WHO) statistics show that 186 million people worldwide, including 45 million couples, are infertile. Furthermore, the integration of technology in fertility test is also anticipated to augment the market growth. For instance, the development of artificial intelligence in IVF could be advantageous to the entire process. According to the National Library of Medicine, AI can recognize human sperm with an accuracy of 89.9% and properly forecast whether a live delivery will occur.
Higher Number of Women Suffering with PCOD & Obesity One of the most prevalent but manageable reasons of infertility in women is PCOS. The hormonal imbalance in PCOS patients prevents the development and release of eggs from the ovaries
PCOS is one of the most common causes of female infertility, affecting 6% to 12% totaled to 5 million women of reproductive age in the United States.
Rising Infertility Cases - According to the National Library of Medicine, 15% of couples worldwide struggle with infertility. Around 20–30% of cases of infertility are caused by males, who also contribute 50% overall.
Increase in the Mean Age of First Motherhood- By the end of 2019, the average age of women experiencing their first pregnancy grew from 29 to 30 internationally, according to figures from the OECD Family Database. The only OECD nation with a mean average age of 28 or less is Mexico.
Higher Consumption of Alcohol, and Tobacco Consumption- Adult drug, alcohol, and tobacco use has increased, which is attributed to busy lifestyles and environmental changes. More than one-third of all male adults globally use tobacco, and over 30% of women of reproductive age smoke, according to BioMed Central Ltd. Smoking has, on average, raised the chance of infertility by 60%. Owing to the alteration in their hormonal levels, both men and women who take substances like marijuana, cocaine, and performance-enhancing drugs likely to have problems getting pregnant.
Better Funding and Insurance Coverage has Increased- The frequency of IVF operations has increased as a result of government assistance in the form of money and insurance coverage across several nations worldwide. Singapore has the most expensive IVF procedures, with expenses ranging from USD 10,000 to USD 15,000 USD per cycle, however the Medicare System covers roughly 95% of the cost, according to a National Library of Medicine report.
Social Stigma Associated with Fertility Tests in Several Countries
Lack of Awareness about Fertility Test in Rural Areas - The lack of accuracy in urine-based monitoring of ovulation, can lead to faulty track of fertile window, and if a couple is trying to conceive, they might miss a crucial period of ovulation. The accuracy can occur due to surge of luteinizing hormone in women who is taking the test, which gives false alarm. Therefore, inaccuracy can affect the growth of fertility test market.
Unproven Accuracy of Urine-Based Ovulation Monitoring
The global fertility test market is segmented and analyzed for demand and supply by end user into home care, fertility clinics, and hospitals. Out of all, the home care segment is anticipated to hold the largest market size by the end of 2035. the segment growth is anticipated on the account of higher number of people using fertility test at home and there have been significant rise in male home-fertility testing as the rate of infertility is constantly increasing. Around 40%-50% of fertility problems in couple is attributed to male fertility.
The North America fertility test market, amongst the market in all the other regions, is projected to hold the largest market share by the end of 2035. The growth of the market in the North America, the market growth is expected to grow on the back of, rise in the cases of infertility. In the United States, 1 in 5 heterosexual women between the ages of 15 and 49 who have never given birth are unsuccessful in getting pregnant after a year of trying (infertility). Additionally, 26% of the women in this group report having trouble getting pregnant or bringing a pregnancy to term. Furthermore, the rise in the average age of women conceiving for the first time is to propel the rate infertility. Birthrates for women in their 20s have decreased, while those for women in their late 30s and early 40s have increased in the U.S. The median age of U.S. women giving birth has increased from 27 to 30, the highest age ever.
Our in-depth analysis of the global fertility test market includes the following segments:
|
By Product |
|
|
By Mode of Purchase |
|
|
By End User |
|
Ans: Rising instances of infertility in both males and females, rising pervasion of PCOD, and rise in the average age of first time motherhood are the few factors which are likely to boost the market growth.
Ans: The market is anticipated to attain a CAGR of ~8% over the forecast period, i.e., 2023 – 2035.
Ans: High costs associated with fertility test kit and low precision of the test results of fertility test kit are estimated to hamper market growth.
Ans: The market in North America is projected to hold the largest market share by the end of 2035 and provide more business opportunities in the future
Ans: The major players in the market are Swiss Precision Diagnostics, Legacy, Inc., Dadi Inc., Everlywell, Inc., Fertility Focus, ExSeed Health, Geratherm Medical, VirtualExpo, AdvaCare Pharma, and others.
Ans: The company profiles are selected based on the revenues generated from the product segment, geographical presence of the company which determine the revenue generating capacity as well as the new products being launched into the market by the company.
Ans: The market is segmented by product, mode of purchase, end-user, and region.
Ans: The home care is anticipated to garner the largest market size by the end of 2035 and display significant growth opportunities.
Submit Your Request For Proposal (RFP)
Submit RFP Buy Now Download Research Report Sample
